Search





Search





News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

Grab Raises 2026 Outlook as Q3 Adjusted EBITDA Jumps 73%

Grab raised its 2026 revenue and adjusted EBITDA outlook after Q3 revenue grew 27%, adjusted EBITDA rose 73%, and Financial Services turned profitable on an adjusted basis.

Grab Holdings Ltd

TradingKey

Tue, Nov 3

Fabrinet Q1 Revenue Rises 51% on Data Center Growth

Fabrinet’s fiscal Q1 2027 revenue rose 51% to a record $1.47 billion as data center sales jumped 78%, while heavy capital spending drove negative free cash flow.

TradingKey

Tue, Nov 3

Emergent BioSolutions Cuts 2026 Outlook After Q3 Revenue Decline

Emergent BioSolutions lowered its 2026 revenue and adjusted EBITDA forecasts after Q3 revenue fell to $110 million on medical countermeasure delivery timing.

Emergent BioSolutions Inc

TradingKey

Tue, Nov 3

BWXT Q3 Revenue Rises 10%, Preliminary 2027 Outlook Signals Earnings Growth

BWXT posted 10% third-quarter revenue growth, a 19% increase in adjusted EBITDA and stronger free cash flow, while outlining its preliminary 2027 outlook.

BWX Technologies Inc

TradingKey

Tue, Nov 3

Bioventus Q3 Sales Rise 3%, 2026 Revenue Seen at $590M-$595M

Bioventus reported 3% Q3 2026 sales growth as Pain Treatments and Ultrasonics offset BGS weakness, while setting 2026 sales guidance at $590 million to $595 million.

TradingKey

Tue, Nov 3

BioMarin Lowers 2026 Outlook Despite Record Q3 Revenue

BioMarin lowered its 2026 revenue and non-GAAP EPS ranges despite record Q3 revenue of $1.025 billion, citing order timing and pipeline costs.

BioMarin Pharmaceutical Inc

TradingKey

Tue, Nov 3

Backblaze Raises 2026 Outlook as B2 Revenue Jumps 47%

Backblaze raised its fiscal 2026 outlook as Q3 revenue grew 26%, B2 Cloud Storage revenue climbed 47%, and adjusted EBITDA margin reached 33%.

TradingKey

Tue, Nov 3

Allison Transmission Q3 Sales Jump 121%, 2026 Outlook Increases

Allison Transmission’s Q3 2026 sales rose 121% to $1.53 billion as its acquired Off-Highway unit added revenue and the legacy business posted record sales.

Allison Transmission Holdings Inc

TradingKey

Tue, Nov 3

Adeia Q3 Revenue Hits $80.2 Million as Licensing Expands

Adeia reported Q3 2026 revenue of $80.2 million, 48% growth in non-Pay-TV recurring revenue and eight licensing agreements while maintaining its full-year outlook.

TradingKey

Tue, Nov 3

Waystar Q3 Revenue Rises 21%, 2026 Margin Outlook at 43%

Waystar’s Q3 2026 revenue rose 21% to $325.6 million, adjusted EBITDA grew 24%, and the company projected 17% full-year revenue growth.

Waystar Holding Corp

TradingKey

Tue, Nov 3

V2X Raises 2026 Guidance as Q3 Revenue Rises 9%

V2X raised its 2026 revenue, adjusted EBITDA, EPS and cash-flow guidance after Q3 revenue rose 9% and backlog reached $12.8 billion.

TradingKey

Tue, Nov 3

Vertex Raises 2026 Revenue Outlook as Q3 Sales Rise 12%

Vertex Pharmaceuticals raised its 2026 revenue guidance after Q3 sales rose 12%, as ALYFTREK and newer products expanded while acquisition and pipeline costs pressured margins.

Vertex Pharmaceuticals Inc

TradingKey

Tue, Nov 3

Travere Q3 U.S. Product Sales Rise 95% as FILSPARI Reaches $200 Million

Travere Therapeutics reported about $220 million in Q3 2026 U.S. net product sales as FILSPARI sales reached $200 million and pipeline programs advanced.

Travere Therapeutics Inc

TradingKey

Tue, Nov 3

Syndax Q3 Revenue Hits $83.3 Million on Drug Growth

Syndax Q3 2026 revenue reached $83.3 million as Revuforj sales and Niktimvo collaboration revenue grew, while its net loss narrowed.

Syndax Pharmaceuticals Inc

TradingKey

Tue, Nov 3

SI-BONE Q3 2026 Revenue Rises 14.5% on Procedure Growth

SI-BONE reported 14.5% Q3 2026 revenue growth to $55.7 million, positive adjusted EBITDA and operating cash flow, while reaffirming its full-year outlook.

TradingKey

Tue, Nov 3

Offerpad Q3 Revenue Falls 41%, Targets Positive EBITDA Run Rate

Offerpad’s Q3 2026 revenue fell 41% as home sales declined, while transaction-level contribution profit improved and management targeted a positive adjusted EBITDA run rate exiting Q2 2027.

Offerpad Solutions Inc

TradingKey

Tue, Nov 3

Neurocrine Raises 2026 INGREZZA Outlook as Q3 Revenue Rises 41%

Neurocrine Biosciences raised its 2026 INGREZZA sales guidance after Q3 revenue grew 41%, with CRENESSITY and VYKAT XR broadening product growth.

Neurocrine Biosciences Inc

TradingKey

Tue, Nov 3

Match Group Q3 Revenue Falls 3% as Payers Decline, EBITDA Rises

Match Group’s Q3 2026 revenue fell 3% as payer declines offset Hinge growth, while adjusted EBITDA rose 14% to $344.5 million.

Match Group Inc

TradingKey

Tue, Nov 3

Jazz Pharmaceuticals Raises 2026 Revenue Guidance After Record Q3 Sales

Jazz Pharmaceuticals raised its 2026 revenue guidance after record third-quarter revenue of $1.24 billion, driven by oncology growth and Xywav.

Jazz Pharmaceuticals PLC

TradingKey

Tue, Nov 3

Ibotta Q3 Revenue Rises 17% as Third-Party Publisher Growth Lifts Adjusted EBITDA

Ibotta’s Q3 2026 revenue rose 17% to $97.8 million and adjusted EBITDA climbed 43%, driven by third-party publisher redemption growth.

TradingKey

Tue, Nov 3

1...27 28 29

29/55

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

Popular Instruments

link

Name

Price

Chg%

link

Nasdaq Rebounds 1% After Yesterday's 5% Slump Led by Tech, SpaceX Shares Jump Over 8%

Today’s Market Recap: Nasdaq Falls Over 5%, AI Stocks Plunge as Nvidia Drops Over 9%, Micron Falls Over 17%, SanDisk Drops Over 22%

Microsoft to drop rented computing capacity from Oracle

Wizstar Launches Wizshot 1.0, Its First In-House Video Generation Model, Making High-Quality AI Video Creation More Cost-Efficient

Berkshire Hathaway Q3 Earnings Preview: Insurance Profits and Cash Deployment in Focus as UBS Raises Class B Price Target to $628

link

Cloudflare Inc Stock (NET) Closed Up by 9.91% on Nov 6: What Investors Need To Know

23 hours ago

Abbott Laboratories Stock (ABT) Closed Down by 3.23% on Nov 6: What Investors Need To Know

Fri, Nov 6

ASE Technology Holding Co Ltd Stock (ASX) Closed Up by 6.43% on Nov 6: Facts Behind the Movement

Fri, Nov 6

Quanta Services Inc Stock (PWR) Closed Up by 6.25% on Nov 6: What Investors Need To Know

Fri, Nov 6

Netflix Inc Stock (NFLX) Closed Down by 3.28% on Nov 6: A Full Analysis

Fri, Nov 6